More on BAYZF
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $52.80 |
|
|||
| Open | $52.80 | ||||
| 52 Wk High | $135.00 | ||||
| 52 Wk Low | $94.95 | ||||
| Day High | $52.80 | ||||
| Day Low | $52.80 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 6,000 | ||||
- New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters
- Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials
- Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming
- The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials
- Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart
- Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon
- Bayer and Iambic partner on AI-driven small molecule drug discovery
- Bayer and Iambic Collaborate to Advance Drug Discovery with AI
- Bayer names Kacy Perry head of Crop Science Canada
- Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
Entities mentioned with BAYZF
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S1 | View Related Stories »
- JPMorgan | View Related Stories »
- Twitter | View Related Stories »
- Show More...
